This might have enriched the results of our study, since we would have been able to confirm as to whether G allele carriers were indeed producing higher levels of IL-6 and assess the influence of IL-6 levels depressive symptom severity and risk of depression episode development in the course of antiviral treatment. Here, IL6 is linked to depressive disorder.